A 155-plex high-throughput in vitro coregulator binding assay for (anti-)estrogenicity testing evaluated with 23 reference compounds

Altex

Volumn 30, Issue 2, 2013, Pages 145-157

  Wang, Si ^a   Houtman, René ^b   Melchers, Diana ^b   Aarts, Jac ^a   Peijnenburg, Ad ^a   Van Beuningen, Rinie ^b   Rietjens, Ivonne ^a   Bovee, Toine F ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b PamGene International   (Netherlands)

Author keywords

Alternative in vitro method; Coregulator; Estrogenicity; In vivo uterotrophic assay; Peptide microarray

Indexed keywords

DIENESTROL; ESTROGEN RECEPTOR ALPHA;

ARTICLE; BINDING ASSAY; CONTROLLED STUDY; CORRELATION ANALYSIS; HIGH THROUGHPUT SCREENING; IN VITRO STUDY; IN VIVO STUDY; MICROARRAY ANALYSIS;

EID: 84877636653     PISSN: 1868596X     EISSN: 18688551     Source Type: Journal    
DOI: 10.14573/altex.2013.2.145     Document Type: Article

References (49)

1. Ascenzi, P., Bocedi, A., and Marino, M. (2006). Structure-function relationship of estrogen receptor [alpha] and [beta]: Impact on human health. Mol Aspects Med 27, 299-402.
2. Bovee, T. F., Helsdingen, R. J., Rietjens, I. M., et al. (2004). Rapid yeast estrogen bioassays stably expressing human estrogen receptors alpha and beta, and green fluorescent protein: a comparison of different compounds with both receptor types. J Steroid Biochem Mol Biol 91, 99-109.
3. Bovee, T. F. And Pikkemaat, M. G. (2009). Bioactivity-based screening of antibiotics and hormones. J Chromatogr A 1216, 8035-8050.
4. Bovee, T. F. H., Bor, G., Becue, I., et al. (2009). Inter-laboratory comparison of a yeast bioassay for the determination of estrogenic activity in biological samples. Anal Chim Acta 637, 265-272.
5. Breinholt, V., Hossaini, A., Svendsen, G. W., et al. (2000). Estrogenic activity of flavonoids in mice. The importance of estrogen receptor distribution, metabolism and bioavailability. Food Chem Toxicol 38, 555-564.
6. Brzozowski, A. M., Pike, A. C. W., Dauter, Z., et al. (1997). Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389, 753-758.
7. Clode, S. A. (2006). Assessment of in vivo assays for endocrine disruption. Best Pract Res Clin Endocrinol Metab 20, 35-43.
8. Couse, J. F. And Korach, K. S. (1999). Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us? Endocr Rev 20, 358-417.
9. Ding, D., Xu, L., Fang, H., et al. (2010). The EDKB: an established knowledge base for endocrine disrupting chemicals. BMC Bioinformatics 11, S5.
10. EC - European Commission (2006). Regulation (EC) No 1907/2006 of the European Parliament and of the Council 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC.
11. Fang, H., Tong, W., Perkins, R., et al. (2000). Quantitative comparisons of in vitro assays for estrogenic activities. Environ Health Perspect 108, 723-729.
12. Gaido, K. W., Leonard, L. S., Lovell, S., et al. (1997). Evaluation of Chemicals with Endocrine Modulating Activity in a Yeast-Based Steroid Hormone Receptor Gene Transcription Assay. Toxicol Appl Pharmacol 143, 205-212.
13. Gustafsson, J. (1999). Estrogen receptor beta-A new dimension in estrogen mechanism of action. J Endocrinol 163, 379-383.
14. Harris, H. A., Katzenellenbogen, J. A., and Katzenellenbogen, B. S. (2002). Characterization of the Biological Roles of the Estrogen Receptors, ERα and ERβ, in Estrogen Target Tissues in Vivo through the Use of an ERα-Selective Ligand. Endocrinology 143, 4172-4177.
15. Heldring, N., Pike, A., Andersson, S., et al. (2007). Estrogen Receptors: How Do They Signal and What Are Their Targets. Physiol Rev 87, 905-931.
16. Hilhorst, R., Houkes, L., van den Berg, A., et al. (2009). Peptide microarrays for detailed, high-throughput substrate identification, kinetic characterization, and inhibition studies on protein kinase A. Anal Biochem 387, 150-161.
17. Hossaini, A., Larsen, J. J., and Larsen, J. C. (2000). Lack of oestrogenic effects of food preservatives (parabens) in uterotrophic assays. Food Chem Toxicol 38, 319-323.
18. Houtman, R., de Leeuw, R., Rondaij, M., et al. (2012). Serine-305 Phosphorylation Modulates Estrogen Receptor Alpha Binding to a Coregulator Peptide Array, with Potential Application in Predicting Responses to Tamoxifen. Mol Cancer Ther 11, 805-816.
19. Hsia, E. Y., Goodson, M. L., Zou, J. X., et al. (2010). Nuclear receptor coregulators as a new paradigm for therapeutic targeting. Adv Drug Deliv Rev 62, 1227-1237.
20. ICCVAM (2003). Evaluation of In Vitro Test Methods for Detecting Potential Endocrine Disruptors: Estrogen Receptor and Androgen Receptor Binding and Transcriptional Activation Assays. NIH Publication No: 03-4503. Research Triangle Park, NC: National Institute of Environmental Health Sciences.
21. ICCVAM (2011). Test Method Evaluation Report. The LUMI-CELL® ER (BG1Luc ER TA) Test Method: An In Vitro Assay for Identifying Human Estrogen Receptor Agonist and Antagonist Activity of Chemicals. NIH Publication No. 11-7850. Research Triangle Park, NC: National Institute of Environmental Health Sciences.
22. Johnson, A. B. And O'Malley, B. W. (2012). Steroid receptor coactivators 1, 2, and 3: Critical regulators of nuclear receptor activity and steroid receptor modulator (SRM)-based cancer therapy. Mol Cell Endocrinol 348, 430-439.
23. Klinge, C. M. (2000). Estrogen receptor interaction with co-Activators and co-repressors. Steroids 65, 227-251.
24. Klinge, C. M., Jernigan, S. C., Smith, S. L., et al. (2001). Estrogen response element sequence impacts the conformation and transcriptional activity of estrogen receptor α. Mol Cell Endocrinol 174, 151-166.
25. Kojetin, D. J., Burris, T. P., Jensen, E. V., et al. (2008). Implications of the binding of tamoxifen to the coactivator recognition site of the estrogen receptor. Endocr Relat Cancer 15, 851-870.
26. Kolle, S. N., Kamp, H. G., Huener, H. A., et al. (2010). In house validation of recombinant yeast estrogen and androgen receptor agonist and antagonist screening assays. Toxicol in Vitro 24, 2030-2040.
27. Kong, E. H., Heldring, N., Gustafsson, J.-Å., et al. (2005). Delineation of a unique protein-protein interaction site on the surface of the estrogen receptor. Proc Natl Acad Sci U S A 102, 3593-3598.
28. Legler, J., van den Brink, C. E., Brouwer, A., et al. (1999). Development of a stably transfected estrogen receptor-mediated luciferase reporter gene assay in the human T47D breast cancer cell line. Toxicol Sci 48, 55-66.
29. Lemeer, S., Jopling, C., Naji, F., et al. (2007). Protein-Tyrosine Kinase Activity Profiling in Knock Down Zebrafish Embryos. PLoS One 2, e581.
30. Lonard, D. M. And O'Malley, B. W. (2012). Nuclear receptor coregulators: modulators of pathology and therapeutic targets. Nat Rev Endocrinol 8, 598-604.
31. Long, X., Fan, M., Bigsby, R. M., et al. (2008). Apigenin inhibits antiestrogen-resistant breast cancer cell growth through estrogen receptor-α-dependent and estrogen receptor-α-independent mechanisms. Mol Cancer Ther 7, 2096-2108.
32. McDonnell, D. P. And Wardell, S. E. (2010). The molecular mechanisms underlying the pharmacological actions of ER modulators: implications for new drug discovery in breast cancer. Curr Opin Pharmacol 10, 620-628.
33. McKenna, N. J., Lanz, R. B., and O'Malley, B. W. (1999). Nuclear Receptor Coregulators: Cellular and Molecular Biology. Endocr Rev 20, 321-344.
34. Mueller, S. O., and Korach, K. S. (2001). Mechanisms of Estrogen Receptor-Mediated Agonistic and Antagonistic Effects. In M. Metzler (ed.), Endocrine Disruptors - Part I (Vol. 3 Series: Anthropogenic Compounds, 1-25). Berlin Heidelberg: Springer.
35. Newbold, R. R., Jefferson, W. N., Padilla-Banks, E., et al. (2001). Cell response endpoints enhance sensitivity of the immature mouse uterotropic assay. Reprod Toxicol 15, 245-252.
36. Owens, J. W. And Ashby, J. (2002). Critical Review and Evaluation of the Uterotrophic Bioassay for the Identification of Possible Estrogen Agonists and Antagonists: In Support of the Validation of the OECD Uterotrophic Protocols for the Laboratory Rodent. Crit Rev Toxicol 32, 445-520.
37. Pedersen, S. N., Christiansen, L. B., Pedersen, K. L., et al. (1999). In vivo estrogenic activity of branched and linear alkylphenols in rainbow trout (Oncorhynchus mykiss). Sci Total Environ 233, 89-96.
38. Pike, A. C. W., Brzozowski, A. M., Hubbard, R. E., et al. (1999). Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. EMBO J 18, 4608-4618.
39. Plotan, M., Elliott, C., Oplatowska, M., et al. (2012). Validation and application of reporter gene assays for the determination of estrogenic and androgenic endocrine disruptor activity in sport supplements. Anal Bioanal Chem 403, 3057-3067.
40. Shang, Y. And Brown, M. (2002). Molecular Determinants for the Tissue Specificity of SERMs. Science 295, 2465-2468.
41. Shelby, M. D., Newbold, R. R., Tully, D. B., et al. (1996). Assessing environmental chemicals for estrogenicity using a combination of in vitro and in vivo assays. Environ Health Perspect 104, 1296-1300.
42. Shiau, A. K., Barstad, D., Loria, P. M., et al. (1998). The Structural Basis of Estrogen Receptor/Coactivator Recognition and the Antagonism of This Interaction by Tamoxifen. Cell 95, 927-937.
43. Sik Kim, H., Seok Kang, T., Hyun Kang, I., et al. (2005). Validation Study of OECD Rodent Uterotrophic Assay for The Assessment of Estrogenic Activity in Sprague-Dawley Immature Female Rats. J Toxicol Environ Health A 68, 2249-2262.
44. van der Burg, B., Winter, R., Weimer, M., et al. (2010). Optimization and prevalidation of the in vitro ERα CALUX method to test estrogenic and antiestrogenic activity of compounds. Reprod Toxicol 30, 73-80.
45. Wang, S., Aarts, J. M. M. J. G., Evers, N. M., et al. (2012). Proliferation assays for estrogenicity testing with high predictive value for the in vivo uterotrophic effect. J Steroid Biochem Mol Biol 128, 98-106.
46. Wang, S., Rijk, J. C. W., Pen, M. J., et al. (2013). A low-density DNA microchip for the detection of (anti-)estrogenic compounds and their relative potencies. Anal Biochem 435; 83-92.
47. Willemsen, P., Scippo, M.-L., Kausel, G., et al. (2004). Use of reporter cell lines for detection of endocrine-disrupter activity. Anal Bioanal Chem 378, 655-663.
48. Yamasaki, K., Takeyoshi, M., Yakabe, Y., et al. (2003). Comparison of the reporter gene assay for ER-Alpha antagonists with the immature rat uterotrophic assay of 10 chemicals. Toxicol Lett 142, 119-131.
49. Zacharewski, T. R., Meek, M. D., Clemons, J. H., et al. (1998). Examination of the in Vitro and in Vitro Estrogenic Activities of Eight Commercial Phthalate Esters. Toxicol Sci 46, 282-293.